Showing 881-890 of 3223 results for "".
Drug Shortages Due to Dual Indications
https://modernod.com/articles/significant-findings/drug-shortages-due-to-dual-indications/37738/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatDemodex Blepharitis Under the Microscope
https://modernod.com/videos/eye-care-insiders/eye-care-insiders-may-2023-video/37325/Joseph Allen, OD, FAAO, Dipl ABO, tackles management of Demodex blepharitis in this month’s episode of Eye Care Insiders. He reviews what causes it, how to identify the signs and symptoms, available treatments and off-label options, patient education, novel therapies in the pipeline, and more.Why You Should Be Fitting Specialty Contact Lenses
https://modernod.com/topics/contact-lenses/why-you-should-be-fitting-specialty-contact-lenses/38601/Points to ponder if you’re not already offering this option in your practice.Reading Is … Bad for Your Eyes?
https://modernod.com/articles/significant-findings/reading-is-bad-for-your-eyes/37732/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatInsight Into Patient Perception of Eye Care
https://modernod.com/articles/significant-findings/insight-into-patient-perception-of-eye-care/37731/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatThe Future of Treating Diabetic Eye Disease?
https://modernod.com/topics/retina/eci-april-2023-video/37324/Joseph Allen, OD, FAAO, Dipl ABO, reviews everything you want to know about novel eye drop OTT166 (OcuTerra Therapeutics), which is in development for the treatment of diabetic retinopathy and diabetic macular edema, including its mechanism of action, pathway to the retina, and promising preliminaryNext Target: Dry AMD
https://modernod.com/articles/significant-findings/next-target-dry-amd/37730/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatCOVID Linked to Rise in Myopia in China
https://modernod.com/articles/significant-findings/covid-linked-to-rise-in-myopia-in-china/37728/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curat64. Get That Money Honey! Ft. Dr. Emilie Seitz
https://modernod.com/podcasts/four-eyes/64-get-that-money-honey-ft-dr-emilie-seitz/37014/Negotiating a contract as a new grad OD can be as terrifying as the first day of Optometry school. That’s why we’ve invited Dr. Emilie Seitz to the Four Eyes podcast to provide tips on negotiating contracts, identifying red flags, discussing money, and how to prioritize your needs. Dr. Seitz also shTwo More Eye Drop Brands Recalled
https://modernod.com/articles/significant-findings/two-more-eye-drop-brands-recalled/37727/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curat